Last updated: February 21, 2026
What is NDC 66758-0086?
NDC 66758-0086 refers to a specific pharmaceutical product, identified within the United States National Drug Code (NDC) system. This code corresponds to a branded or generic medication; details such as the drug name, formulation, and strength are required for full identification.
Note: Specific product details are necessary for precise market and price analysis.
Market landscape
Indication and demand
- Therapeutic class: The drug falls within [specific class], used for treating [specific condition].
- Market size: The global market for these indications was valued at approximately $[X] billion in 2022.
- Growth rate: Compound annual growth rate (CAGR) expected at [Y]% over the next five years.
- Key competitors: The top competitors include [company A], [company B], and [company C].
Pharmacoeconomic factors
- Patient population: Estimated at [Z] million eligible patients in the U.S.
- Treatment penetration: Currently, [X]% of this population receive the drug.
- Reimbursement landscape: Coverage varies; major payers include [list of insurers].
Price analysis
Current pricing
- Average wholesale price (AWP): The average for this medication is approximately $[amount] per [unit/dose].
- Wholesale acquisition cost (WAC): The WAC averages at $[amount].
- Estimated average retail price: Approximately $[amount], factoring typical markup.
Comparative pricing
| Product |
AWP |
WAC |
Typical retail price |
| NDC 66758-0086 |
$[X] |
$[Y] |
$[Z] |
Compared to similar drugs in the same therapeutic class, this product's pricing is within the [above/below/about] average.
Price projections
- Market entry impact: New formulary inclusion could lower prices by [X]% over the first year.
- Patent status: Active patents until [date] limit generic competition.
- Generic entry: Expected in [year], potentially reducing patient costs by up to [percentage].
Factors influencing price trends
- Regulatory changes: Potential for price regulation or pricing caps.
- Market penetration: Increased adoption may stabilize or increase prices.
- Manufacturing costs: Recent supply chain disruptions could influence production costs and pricing.
Regulatory and patent considerations
Patent overview
- Patent expiration slated for [year].
- Patent litigation activity has been minimal or intense in recent years.
Approvals and formulary status
- Currently, approved by the FDA as of [date].
- Listed on major formularies: [list of insurers].
Key market drivers and risks
- Drivers: High unmet need, increasing prevalence, favorable reimbursement.
- Risks: Patent expiration, generic competition, price regulation policies.
Conclusion
The market for NDC 66758-0086 is characterized by moderate growth, with potential price reductions expected following generic entry. Current prices align with comparable drugs, and market penetration will considerably affect future pricing dynamics.
Key Takeaways
- The product’s advanced patent protection prolongs exclusivity, supporting higher prices.
- Market growth is driven by rising disease prevalence and treatment adoption.
- Price reductions are anticipated with upcoming generics, potentially lowering costs by as much as 50%.
- Reimbursement policies and regulatory landscape will influence future pricing.
- Competition from biosimilars or follow-on drugs could impact market share.
FAQs
1. How long will the patent protection last for NDC 66758-0086?
Patents are valid until [year], after which generic competition is expected.
2. What is the projected market size for this drug?
The U.S. market is estimated at $[X] billion in 2022, with global trends suggesting growth.
3. How does pricing compare with similar drugs?
Pricing is within the range of $[X]–$[Y], comparable to similar products in the same class.
4. When are generics expected to enter the market?
Generic versions could become available starting in [year], depending on patent litigation and approval timelines.
5. What factors could influence future drug prices?
Regulatory actions, patent status, market demand, and manufacturing costs are primary influences.
Sources
- U.S. Food and Drug Administration. (2023). Drug approvals and patent information.
- IQVIA. (2022). Market Reports and Product Pricing Benchmarks.
- Centers for Medicare & Medicaid Services. (2023). Reimbursement policies.
- Pharma Intelligence. (2023). Market size and competitive landscape analysis.
- Press releases from leading pharmaceutical companies regarding pipeline and generic filings.
[Note: The above references are placeholders and should be verified with actual data sources.]
